A detailed history of Wolverine Trading, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 471,800 shares of MRNA stock, worth $19 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
471,800
Previous 2,080 22582.69%
Holding current value
$19 Million
Previous $247,000 12665.18%
% of portfolio
0.03%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $2.06 Million - $3.4 Million
-20,379 Reduced 90.74%
2,080 $247,000
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $6.5 Million - $8.79 Million
-76,162 Reduced 77.23%
22,459 $2.39 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $5.63 Million - $8.45 Million
80,944 Added 457.91%
98,621 $9.81 Million
Q3 2023

Nov 15, 2023

SELL
$96.41 - $126.61 $759,807 - $997,813
-7,881 Reduced 30.84%
17,677 $1.83 Million
Q2 2023

Aug 23, 2023

BUY
$118.5 - $160.53 $2.62 Million - $3.55 Million
22,085 Added 635.91%
25,558 $3.11 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $160,621 - $233,271
-1,184 Reduced 25.42%
3,473 $512,000
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $319,152 - $566,267
2,696 Added 137.48%
4,657 $836,000
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $4.84 Million - $7.96 Million
-41,002 Reduced 95.44%
1,961 $232,000
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $3.22 Million - $4.86 Million
-27,514 Reduced 39.04%
42,963 $6.14 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $7.95 Million - $14.8 Million
-62,876 Reduced 47.15%
70,477 $12.3 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $25.5 Million - $41.5 Million
112,706 Added 545.87%
133,353 $33.6 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $2.37 Million - $5.18 Million
10,684 Added 107.24%
20,647 $7.82 Million
Q2 2021

Aug 06, 2021

SELL
$129.91 - $234.98 $3.65 Million - $6.61 Million
-28,134 Reduced 73.85%
9,963 $2.34 Million
Q1 2021

May 14, 2021

SELL
$109.18 - $185.98 $257,883 - $439,284
-2,362 Reduced 5.84%
38,097 $4.51 Million
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $1.35 Million - $3.49 Million
20,564 Added 103.36%
40,459 $4.5 Million
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $337,886 - $589,777
6,218 Added 45.46%
19,895 $1.4 Million
Q1 2020

May 11, 2020

BUY
$17.78 - $31.58 $243,177 - $431,919
13,677 New
13,677 $417,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.